Questions relating to supply of COVID-19 “vaccines”

ASE made this Official Information request to Ministry of Business, Innovation & Employment

Response to this request is long overdue. By law Ministry of Business, Innovation & Employment should have responded by now (details and exceptions). You can complain to the Ombudsman.

From: ASE

Attention Ministry of Business, Innovation & Employment,

What role did The Ministry of Business, Innovation & Employment have in negotiating supply contracts for COVID-19 “vaccines”, inoculations, or any other preventative treatments (hereinafter referred to as “treatments”)?

Regarding the negotiation of supply contracts and related matters for such treatments; what other persons, boards, councils, committees, subcommittees, organisations, groups, bodies, agencies, ministries, or individuals exerted influence in any capacity?

Regarding the negotiation of supply contracts and related matters for such treatments; are there contractual conditions which could expose any party or parties within New Zealand to liability for damages? If so, what are those conditions?

Regarding the negotiation of supply contracts and related matters for such treatments; are there contractual conditions which influence messaging about safety and efficacy of such treatments? If so, what are those conditions?

Are there any contractual obligations which limit or otherwise exert influence over the reporting or public release of data relating to the administration, safety, and/or efficacy, of such treatments?

Has The Ministry of Business, Innovation & Employment contracted, or facilitated, or have any information relating to; any payments to, or on behalf of, any person or persons, as a result of actual or possible injury, resulting from administration of such treatments?

Has The Ministry of Business, Innovation & Employment contracted, or facilitated, or have any information relating to; any non-disclosure agreements, confidentiality agreements, or similar instruments in relation to any person or persons, as a result of actual or possible injury, resulting from administration of such treatments?

Thank you,
ASE

Link to this

From: Ministerial Services
Ministry of Business, Innovation & Employment

Kia ora,
Thanks for your email.
The Strategy, Performance and Operations team are on Christmas leave, and
this inbox will not be monitored until the 5th January 2021.
Your email will be processed on our return into the office.
Meri Kirihimete!
Ngā mihi nui, SPO
Ministerial Services

[1]www.govt.nz - your guide to finding and using New Zealand government
services

show quoted sections

References

Visible links
1. http://www.govt.nz/

Link to this

From: Ministerial Services
Ministry of Business, Innovation & Employment


Attachment image001.jpg
7K Download


Ref: 2122-1350

 

Dear ASE,

 

On behalf of the Ministry of Business, Innovation and Employment I
acknowledge your email of the 3^rd of January 2022 requesting under the
Official Information Act 1982 (the Act), the following:

 

“What role did The Ministry of Business, Innovation & Employment have in
negotiating supply contracts for COVID-19 “vaccines”, inoculations, or any
other preventative treatments (hereinafter referred to as “treatments”)?

Regarding the negotiation of supply contracts and related matters for such
treatments; what other persons, boards, councils, committees,
subcommittees, organisations, groups, bodies, agencies, ministries, or
individuals exerted influence in any capacity?

Regarding the negotiation of supply contracts and related matters for such
treatments; are there contractual conditions which could expose any party
or parties within New Zealand to liability for damages? If so, what are
those conditions?

Regarding the negotiation of supply contracts and related matters for such
treatments; are there contractual conditions which influence messaging
about safety and efficacy of such treatments? If so, what are those
conditions?

Are there any contractual obligations which limit or otherwise exert
influence over the reporting or public release of data relating to the
administration, safety, and/or efficacy, of such treatments?

Has The Ministry of Business, Innovation & Employment contracted, or
facilitated, or have any information relating to; any payments to, or on
behalf of, any person or persons, as a result of actual or possible
injury, resulting from administration of such treatments?

Has The Ministry of Business, Innovation & Employment contracted, or
facilitated, or have any information relating to; any non-disclosure
agreements, confidentiality agreements, or similar instruments in relation
to any person or persons, as a result of actual or possible injury,
resulting from administration of such treatments?”

 

Your request is being processed in accordance with the Act and a response
will be sent to you in due course.

 

Please note that the days from 25 December 2021 to 15 January 2022
(inclusive) are defined as non- working days in the Act and are not
counted in the calculation of the maximum timeframe for our response to
your request. This will affect the time period for responding to your
request.

 

If you have any enquiries regarding your request feel free to contact us
via email [1][MBIE request email] or using the contact details below.

 

Nâku noa, nâ

MINISTERIAL SERVICES

 

Ngâ Pou o te Taumaru

Ministry of Business, Innovation & Employment

15 Stout Street, Wellington 6011 |  P O Box 1473 Wellington 6140

 

 

[2]www.govt.nz - your guide to finding and using New Zealand government
services

show quoted sections

References

Visible links
1. mailto:[MBIE request email]
2. http://www.govt.nz/

Link to this

From: RSI-thehive
Ministry of Business, Innovation & Employment


Attachment image001.jpg
2K Download

Attachment DOIA 2122 1350 ASE MBIE Response Letter.pdf
189K Download View as HTML

Attachment DOIA 2122 1350 Documents.pdf
10.2M Download View as HTML


Good evening ASE,

 

Please see attached for MBIE’s response letter to your Official
Information Act request.

 

Kind regards,

Lisa

 

Lisa Seng (she/her)

Project Co-ordinator

[1]Description: Description: Description: Description: Description:
Description: Description: cid:image001.jpg@01CD1D45.D6A244C0

MINISTRY OF BUSINESS INNOVATION & EMPLOYMENT / HIKINA WHAKATUTUKI

PO Box 1473 Wellington

 

[2]www.govt.nz - your guide to finding and using New Zealand government
services

show quoted sections

References

Visible links
2. http://www.govt.nz/

Link to this

From: ASE

Attn Ministry of Business, Innovation & Employment;

Thank you for that response.

I note that some of the requested information has not been provided: “Regarding the negotiation of supply contracts and related matters for such treatments; are there contractual conditions which influence messaging about safety and efficacy of such treatments? If so, what are those conditions?”

Thank you,
ASE

Link to this

From: RSI-thehive
Ministry of Business, Innovation & Employment

Dear ASE,

This is covered in the paragraph referring to the confidentiality of the details of our contracts with our vaccine suppliers, which have been withheld under s9(2)(ba)(ii). The Medicines Act 1981 also governs what information vaccine suppliers must provide about the safety and efficacy of their products. As noted in our letter to you, there are no clauses in the government's contracts with vaccine suppliers that exempt them from meeting any of Medsafe's regulatory requirements.

Regards,
Lisa

Lisa Seng (she/her)
Project Co-ordinator
Labour, Science and Enterprise Group

MINISTRY OF BUSINESS INNOVATION & EMPLOYMENT / HIKINA WHAKATUTUKI

show quoted sections

Link to this

From: ASE

Attn Ministry of Business, Innovation & Employment,

Thank you for that response.

As it relates to the question; “Regarding the negotiation of supply contracts and related matters for such treatments; are there contractual conditions which influence messaging about safety and efficacy of such treatments? If so, what are those conditions?”

My question is not intended to inquire about what information suppliers must provide about the safety and efficacy of their products, and I apologise if that was not clear, rather this question is about how government agencies or any other parties may be under contractual limitations regarding release of any safety and efficacy information to the media and/or public. eg, are there contractual conditions relating to media or public release of information which might lead to "vaccine hesitancy", or otherwise reflect poorly on the safety or efficacy of these treatments? Are there any other contractual conditions which may limit government agencies or any other parties from releasing any safety and efficacy information to the media and/or public? Or, does the contract (and related contracts) allow all parties to freely and publicly disclose all safety and efficacy data, without restriction?

Thank you,
ASE

Link to this

Things to do with this request

Anyone:
Ministry of Business, Innovation & Employment only: